These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7789952)

  • 1. Recurrence of osteogenesis imperfecta because of paternal mosaicism: Gly862-->Ser substitution in a type I collagen gene (COL1A1).
    Namikawa C; Suzumori K; Fukushima Y; Sasaki M; Hata A
    Hum Genet; 1995 Jun; 95(6):666-70. PubMed ID: 7789952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a mutation in the COL1A2 gene of type I collagen. The mosaic parent exhibits phenotypic features of a mild form of the disease.
    Edwards MJ; Wenstrup RJ; Byers PH; Cohn DH
    Hum Mutat; 1992; 1(1):47-54. PubMed ID: 1301191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dominant mutation in the COL1A1 gene that substitutes glycine for valine causes recurrent lethal osteogenesis imperfecta.
    Bonaventure J; Cohen-Solal L; Lasselin C; Maroteaux P
    Hum Genet; 1992 Aug; 89(6):640-6. PubMed ID: 1511982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable expression of osteogenesis imperfecta in a nuclear family is explained by somatic mosaicism for a lethal point mutation in the alpha 1(I) gene (COL1A1) of type I collagen in a parent.
    Wallis GA; Starman BJ; Zinn AB; Byers PH
    Am J Hum Genet; 1990 Jun; 46(6):1034-40. PubMed ID: 2339700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paternal mosaicism for a COL1A1 dominant mutation (alpha 1 Ser-415) causes recurrent osteogenesis imperfecta.
    Mottes M; Gomez Lira MM; Valli M; Scarano G; Lonardo F; Forlino A; Cetta G; Pignatti PF
    Hum Mutat; 1993; 2(3):196-204. PubMed ID: 8364588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gly802Asp substitution in the pro alpha 2(I) collagen chain in a family with recurrent osteogenesis imperfecta due to paternal mosaicism.
    Lund AM; Schwartz M; Raghunath M; Steinmann B; Skovby F
    Eur J Hum Genet; 1996; 4(1):39-45. PubMed ID: 8800927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrafamilial variable expressivity of osteogenesis imperfecta due to mosaicism for a lethal G382R substitution in the COL1A1 gene.
    Cohen-Solal L; Zolezzi F; Pignatti PF; Mottes M
    Mol Cell Probes; 1996 Jun; 10(3):219-25. PubMed ID: 8799376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a Gly862 to Ser substitution in the type I collagen gene from a single spermatozoon.
    Iida T; Suzumori K; Ikuta K; Tanemura M; Yagami Y; Okamoto T; Hata A
    Mol Hum Reprod; 1996 Feb; 2(2):131-4. PubMed ID: 9238670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a dominant mutation in a human type I collagen gene (COL1A1).
    Cohn DH; Starman BJ; Blumberg B; Byers PH
    Am J Hum Genet; 1990 Mar; 46(3):591-601. PubMed ID: 2309707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gly511 to Ser substitution in the COL1A1 gene in osteogenesis imperfecta type III patient with increased turnover of collagen.
    Galicka A; Wołczyński S; Gindzieński A; Surazyński A; Pałka J
    Mol Cell Biochem; 2003 Jun; 248(1-2):49-56. PubMed ID: 12870654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serine for glycine substitutions in type I collagen in two cases of type IV osteogenesis imperfecta (OI). Additional evidence for a regional model of OI pathophysiology.
    Marini JC; Lewis MB; Wang Q; Chen KJ; Orrison BM
    J Biol Chem; 1993 Feb; 268(4):2667-73. PubMed ID: 8094076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-specific mosaicism for a lethal osteogenesis imperfecta COL1A1 mutation causes mild OI/EDS overlap syndrome.
    Symoens S; Steyaert W; Demuynck L; De Paepe A; Diderich KE; Malfait F; Coucke PJ
    Am J Med Genet A; 2017 Apr; 173(4):1047-1050. PubMed ID: 28261977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parental mosaicism and autosomal dominant mutations causing structural abnormalities of collagen I are frequent in families with osteogenesis imperfecta type III/IV.
    Lund AM; Nicholls AC; Schwartz M; Skovby F
    Acta Paediatr; 1997 Jul; 86(7):711-8. PubMed ID: 9240878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mild dominant osteogenesis imperfecta with intrafamilial variability: the cause is a serine for glycine alpha 1(I) 901 substitution in a type-I collagen gene.
    Mottes M; Sangalli A; Valli M; Gomez Lira M; Tenni R; Buttitta P; Pignatti PF; Cetta G
    Hum Genet; 1992 Jul; 89(5):480-4. PubMed ID: 1634225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic heterogeneity in osteogenesis imperfecta: the mildly affected mother of a proband with a lethal variant has the same mutation substituting cysteine for alpha 1-glycine 904 in a type I procollagen gene (COL1A1).
    Constantinou CD; Pack M; Young SB; Prockop DJ
    Am J Hum Genet; 1990 Oct; 47(4):670-9. PubMed ID: 2220807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new mutation in COL1A1 gene in a family with osteogenesis imperfecta].
    Wang Z; Xu DL; Chen Z; Hu JY; Yang Z; Wang LT
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(3):170-3. PubMed ID: 16638323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteogenesis imperfecta type IV. Detection of a point mutation in one alpha 1(I) collagen allele (COL1A1) by RNA/RNA hybrid analysis.
    Marini JC; Grange DK; Gottesman GS; Lewis MB; Koeplin DA
    J Biol Chem; 1989 Jul; 264(20):11893-900. PubMed ID: 2745420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence of normal canine COL1A1 cDNA and identification of a heterozygous alpha1(I) collagen Gly208Ala mutation in a severe case of canine osteogenesis imperfecta.
    Campbell BG; Wootton JA; MacLeod JN; Minor RR
    Arch Biochem Biophys; 2000 Dec; 384(1):37-46. PubMed ID: 11147834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative splicing in COL1A1 mRNA leads to a partial null allele and two In-frame forms with structural defects in non-lethal osteogenesis imperfecta.
    Wang Q; Forlino A; Marini JC
    J Biol Chem; 1996 Nov; 271(45):28617-23. PubMed ID: 8910493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteogenesis imperfecta type I: molecular heterogeneity for COL1A1 null alleles of type I collagen.
    Willing MC; Deschenes SP; Scott DA; Byers PH; Slayton RL; Pitts SH; Arikat H; Roberts EJ
    Am J Hum Genet; 1994 Oct; 55(4):638-47. PubMed ID: 7942841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.